Mali, like many sub-Saharan African nations, is currently navigating a dual epidemiological burden. While infectious diseases remain a concern, non-communicable diseases (NCDs)—specifically cardiovascular diseases (CVDs)—are rising at an unprecedented rate. Statistics from the Mali Ministry of Health indicate that hypertension and heart failure now account for a significant percentage of adult outpatient visits in Bamako and regional capitals.
As a leading Cardiovascular Drugs Supplier and Exporter, we recognize that the Malian market requires more than just product delivery. It requires information gain: understanding the thermal stability requirements for desert climates, the regulatory nuances of the Direction de la Pharmacie et du Médicament (DPM), and the logistics of the Sahelian supply chain.
Global pharmaceutical procurement for Mali often faces hurdles such as volatile exchange rates, long lead times, and stringent customs regulations. Hangzhou Jeci Biochem Technology Co., Ltd. bridges this gap by offering a vertically integrated supply chain model.
We utilize advanced Phase Change Materials (PCM) for temperature-sensitive cardiovascular drugs, ensuring efficacy from our GMP labs to the pharmacies in Bamako.
Our team handles the dossier preparation for DPM registration, ensuring all APIs and finished formulations meet Mali's evolving healthcare standards.
Collaborative research into heat-stable oral solutions and tablets specifically designed for regions with high ambient temperatures.
Our production facilities utilize AI-driven batch monitoring to ensure every milligram of an active ingredient—be it Enalapril Maleate or Calcium Gluconate—meets USP/BP/EP pharmacopoeia standards. For Mali, we have developed a roadmap that integrates digital traceability, allowing local exporters to verify the authenticity of shipments via QR code technology.
Production Application:
Based in Hangzhou, Zhejiang, Hangzhou Jeci Biochem Technology Co., Ltd. is a powerhouse in the pharmaceutical export sector. Our expertise spans from API sales to custom R&D and international trade relations with key markets including India, Southeast Asia, and the emerging West African corridor.
Deep collaboration with research institutes and exclusive agency rights for multiple high-demand therapeutic products.
Long-term trade relations and full-process market services ensuring that our cardiovascular drugs reach the patient safely.
We provide factory quality management system certification services, proving our commitment to global healthcare excellence.
All our products are manufactured in WHO-GMP certified facilities. We provide COA (Certificate of Analysis) for every batch and utilize specialized packaging to prevent degradation during transit through high-temperature regions like the Sahel.
Yes, we offer OEM and custom logo services, including French-language packaging (Mali's official language) to comply with local pharmaceutical regulations and improve patient adherence.
Depending on the product type (API vs. Finished Formulation), lead times range from 4 to 8 weeks, including sea freight to the port (usually Dakar or Abidjan) and overland transit to Mali.
Absolutely. We provide the CTD (Common Technical Document) dossiers required for product registration and offer consulting on local regulatory hurdles.
SJ medical
